Login to Your Account


LONDON – Going back to the roots of antibiotic discovery, a new Oxford University spinout has turned to natural product libraries to uncover recurring motifs that can be translated into novel synthetic chemistry.

SHANGHAI – Newly founded biopharma Harbour Biomed Therapeutics Ltd., of Shanghai, has acquired privately held Harbour Antibody BV, of Cambridge, Mass.

"We're on the precipice of being able to crack open the science [in neurology]," Amanda Christini, president of Blackfynn Inc., told BioWorld Today. Spun out at the start of 2015 from the University of Pennsylvania, the organization consists of an 11-person team of experts in neurology, neuroscience, computer science, medicine and engineering.

More Newco News Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: